NESTED THERAPEUTICS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.nestedtx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Phase 1
Recruiting
- Conditions
- MEK MutationSolid Tumor, AdultRAF Gene MutationNSCLCOncologyRas (KRAS or NRAS) Gene MutationMAPK Pathway Gene MutationMelanomaGlioma
- Interventions
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Nested Therapeutics, Inc
- Target Recruit Count
- 230
- Registration Number
- NCT06326411
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸UCLA Hematology/Oncology, Westwood, California, United States
🇺🇸Sarah Cannon Research Institute at Health ONE, Denver, Colorado, United States
News
No news found